Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 4Interventional 3

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Thyroid Neoplasms 1Polycystic Ovary Syndrome 1Menstruation Disturbances 1Lymphoma, T-Cell, Cutaneous 1Hypertriglyceridemia 1Hyperthyroidism 1Graves Disease 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Glucose Tolerance Test × Clear all
NCT07410637 2026-02-13

Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

University of Ulm

Phase NA Recruiting
60 enrolled
Head & Neck

Graves Disease, Hyperthyroidism, Thyroid Neoplasms

NCT01569724 2017-07-21

TgBEX

Rennes University Hospital

Phase 4 Completed
10 enrolled
DermatologicLymphoid

Hypertriglyceridemia, Lymphoma, T-Cell, Cutaneous

NCT00283816 2015-05-15

Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

University of Rochester

Phase 3 Completed
36 enrolled 9 charts

Menstruation Disturbances, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡